Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-28 @ 11:02 AM
Study NCT ID:
NCT05743335
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2023-02-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine
Sponsor:
Immorna Biotherapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2023-02-22
First Submit QC Date:
None
Study First Post Date:
2023-02-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-09
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL